학술논문

DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2
Document Type
Journal
Source
CANCER RESEARCH; JAN 1 2024, 84 1, 2p. Supplement: S
Subject
Language
English
ISSN
15387445